Total hip arthroplasty (THA) has shown good clinical outcomes and high rates of long-term survival in patients with end-stage hip diseases.[@B1] However, it remains difficult to treat a patient complicated with an ankylosed hip joint[@B2] because the preceding lesion results in changes in bony structure, contracture of soft tissue, atrophy of the external rotator, and acetabular subchondral bone defects.[@B3]

Ankylosing spondylitis (AS) results in severe limitation of motion and functional disability, which affects posture and gait. AS tends to manifest at a younger age and the extent of skeletal involvement can vary widely. The accompanying pain and impaired gait severely disturb daily life activities. The incidence of hip involvement in AS is between 30% and 50%, and 47% to 90% of patients have it bilaterally. Several reports have focused on the treatment of AS with THA showing excellent outcomes and suggest THA as the most well-established treatment of choice for AS with severe hip involvement.[@B2][@B3][@B4] However, the exact location for the implant is difficult to determine during the operation due to changes in bony structure of the lesion.[@B4] In addition, the balance among the vertebral column, pelvis, and lower extremities should also be considered when performing THA in AS patients. A number of studies have reported postoperative loosening of the acetabular component and heterotopic ossification ([Table 1](#T1){ref-type="table"}).[@B2][@B5][@B6][@B7] However, few reports have evaluated subsequent surgical outcomes and compared with the results of other diseases involving the hip joint such as osteonecrosis of the femoral head or of primary osteoarthritis (OA).[@B4] Therefore, the objective of this study was to analyze outcomes of cementless THA in patients with AS and also clinically and radiologically compare patients with AVN of the femoral head who underwent the same procedure.

METHODS
=======

Thirty patients (30 hips) with AS underwent THA between 2003 and 2012. These patients were followed for \> 4 years. Their mean patient age was 39.6 years (range, 22 to 55 years) at the time of the operation. Twenty-six patients were male, and 4 were female. All hips underwent unilateral procedure. The mean follow-up period was 69.0 months (range, 50 to 118 months). The control group was selected from patients with avascular necrosis (AVN) of the femoral head, who underwent the same cementless hip arthroplasty procedure during the same period. The mean age of the patients in the control group (30 patients, 30 hips) were 42.6 years (range, 33 to 58 years). Twenty-six were male, and 4 were female, and the mean follow-up period was 71.5 months (range, 50 to 110 months) ([Table 2](#T2){ref-type="table"}).

Surgical Technique
------------------

All surgeries were performed by the same surgeon (TRY). Cementless implants were used as the fixation method for both the acetabular cup and femoral stem. Minimally invasive two-incision technique was used in all hips.[@B8] Placing the patient in a lateral decubitus position, we utilized the Watson-Jones anterolateral approach to insert the acetabular component and made a posterior incision through the intermuscular interval between the gluteus medius and piriformis for femoral component insertion.

Ceramic-on-ceramic hips were implanted in all patients and data on all acetabular cups and femoral stems are described in [Table 2](#T2){ref-type="table"}. An adductor tenotomy was performed after implantation in all hips except for one in the AVN group. Drains were removed when drain volume decreased to \< 100 mL daily. Tolerable weight bearing ambulation with an ambulatory assistance device was prescribed the day after surgery.

Evaluation
----------

Clinical variables including the mean operation time, drain volume, the arc of range of motion (ROM), pre- and postoperative Harris Hip Score (HHS)[@B9] were compared between the 2 groups. Radiological evaluations were performed on the angle of articular cup anteversion[@B1] and inclination, femoral stem slope, and pre- and postoperative leg length discrepancy ([Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).[@B10][@B11][@B12] Postoperative complications such as radiological evidence of aseptic or septic loosening, heterotopic ossification, and deep infection were evaluated ([Fig. 3](#F3){ref-type="fig"}).[@B13]

Statistical Analysis
--------------------

Demographic characteristics, clinical outcomes, radiological outcomes, and complications were compared between the 2 groups using the independent *t*-test. Kolmogorov-Smirnov test was used to determine normal distributions. All data were analyzed using IBM SPSS ver. 20.0 (IBM Co., Armonk, NY, USA). Statistical significance was defined as *p*-value less than 0.05 (two-tailed).

RESULTS
=======

The operation time was longer in the AS group than in the AVN group (120.2 ± 26.2 min vs. 79.5 ± 11.1 min; *p* = 0.007). Postoperative drainage volume was 764.5 ± 355.4 mL and 510.5 ± 195.6 mL in the AS group and AVN group, respectively (*p* = 0.004).

Preoperative HHS was different between the AS group and AVN group (55.6 ± 13.8 vs. 59.2 ± 2.8; *p* = 0.001). Similarly, postoperative HHS at the last follow-up was significantly lower in the AS group than in the AVN group (92.8 ± 2.8 in AS vs. 97.4 ± 2.6 in AVN; *p* \< 0.05).

Preoperative arc of ROM was 146.5° ± 13.2° in the AS group, which was improved to 254.7° ± 17.2° postoperatively. In the AVN group, the value was improved from 182.6° ± 15.5° to 260.4° ± 13.7°.

No differences in the angle of articular cup anteversion or inclination or femoral stem slope were detected between the groups in the radiological evaluation. Postoperative leg length discrepancy was 2.3 ± 5.7 mm in the AS group and 3.4 ± 2.5 mm in the AVN group (*p* = 0.240).

The AS group had 3 cases of heteroscopic ossification, whereas 1 case was observed in the AVN group. Of the 4 heteroscopic ossification cases, 1 was Brooker classification I, and 3 were Brooker classification III ([Table 3](#T3){ref-type="table"}). One deep tissue infection and one femoral stem loosening ([Fig. 2](#F2){ref-type="fig"}) were identified during follow-up in the AS group ([Table 4](#T4){ref-type="table"}).

DISCUSSION
==========

AS is a chronic rheumatologic disease affecting 1% of the population. Hip involvement in AS is between 30% and 50%, and the disease may be bilateral in 47%--90% of patients. [@B14][@B15][@B16][@B17] However, most published studies have a small number of cases or a short follow-up.

Recent advances in implant surgery have resulted in improvement of techniques producing better outcomes after cementless THA. Still, THA in patients with AS is far more challenging due to the conditions accompanying osteoarthritic changes or secondary structural abnormalities. The lengthy immovable state of the joint induces soft tissue contracture and a distorted anatomical relationship, which produces deceptive anatomical landmarks leading to poor implant placement.[@B14][@B15][@B16] Hence, long-term outcomes of THA are worse in patients with AS.[@B17]

Several studies have reported clinical results after THA in patients with AS. Tang and Chiu[@B11] reported a 63.6% survival rate at 11 years of follow-up of patients who underwent cementless THA. Kim et al.[@B12] also reported that 3 of 24 ankylosed hips that underwent cementless THA developed osteolysis and 2 developed aseptic loosening. They concluded that fixation of the hip joints in an external position in patients with bilateral hip ankylosis resulted in poor positioning of the implant and poor long-term results.[@B12] In contrast, Ye et al.[@B14] reported good outcomes of THA performed in 15 hip ankylosis cases.

Treatment of AS is theoretically a modifiable risk factor. In this study, we considered AS a cause of ankylosed hips and analyzed the clinical and radiological results after THA. Then, we compared the results with those from AVN of the femoral head cases. After a mean of 69 months (range, 50 to 118 months) of follow-up, only 1 case of femoral stem loosening was found in the AS group, without any cases of acetabular loosening or dislocation. This can be attributed to implantation of the acetabular cup and femoral stem at proper angles, resulting in a normal angle of articular cup anteversion and inclination and femoral stem slope. However, the operation time and postoperative drain volume increased significantly, suggesting that patients with AS must be closely followed for infection. Postoperative HHS was different between the groups; however, mean scores were \> 90 in both groups.

As other studies have suggested, the AS group had a higher prevalence of heteroscopic ossification. Heterotopic ossification results from differentiation of mesenchymal cells into osteoprogenitor cells, although the precise pathway remains unknown. The natural setting of heterotopic ossification is extraarticular outside the joint capsule.[@B18][@B19] Superficial or deep infections are a risk factor for heterotopic ossification.[@B2][@B20][@B21] Furthermore, preoperative hip ankylosis and postoperative infection are major risk factors for heterotopic ossification.[@B6][@B7][@B22][@B23][@B24] In the AS group, we only observed one deep infection in a patient who developed grade III heterotopic ossification. More studies are needed with different patient groups and longer follow-up times to verify this finding.

The lower incidence of heterotopic ossification in our patients was likely due to less muscle damage during the surgery using a minimally invasive technique. Minimally invasive THA with the modified two-incision technique facilitated proper implantation of the acetabular cup and stem and minimized muscle damage and other postoperative complications, ultimately resulting in excellent outcomes in patient with AS.

This study has some limitations. The study was retrospective with the inherent potential for inaccurate medical records and information bias. The relatively small study population could have weakened the power of the analysis. In addition, patient selection was not perfectly randomized because it was based on diagnosis and matching demographics. However, the strength of this study is that that all operations were performed by the same surgeon. Moreover, as far as we are aware this is the first study comparing the outcomes of THA between patients with AS and those with AVN of the femoral head. Several reports have suggested that THA is the most preferred treatment for AS with severe hip involvement. However, there is a lack in comparison studies with other hip diseases containing subsequent surgical outcomes.

Surgeons may have some concerns about the longterm outcome in young patients who undergo THA. Several reports have shown excellent functional results with long survival rates of the implant in AS.[@B14][@B15][@B16] However, there is a paucity in the literature on systematic comparison of AS with other inflammatory diseases involving the hip joint. In our study, significant functional improvement could be achieved after THA in patients with AVN as well as AS.

In conclusions, cementless THA in patients with AS showed satisfactory mid-term results, despite the longer operation time, larger blood loss, and lower HHS than in patients with AVN of the femoral head. Thus, patients with AS must be closely followed with more intense postoperative care than those with AVN. The results of this study suggest that cementless THA is an effective and reliable treatment in both AS and AVN.
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![Radiographs of a patient with ankylosing spondylitis who underwent primary cementless total hip arthroplasty. (A) Preoperative radiograph. (B) One-year postoperative radiograph. (C) Three-year postoperative radiograph.](cios-9-263-g001){#F1}

![Radiographs of a patient with avascular necrosis of the femoral head who underwent primary cementless total hip arthroplasty. (A) Preoperative radiograph. (B) One-year postoperative radiograph. (C) Three-year postoperative radiograph.](cios-9-263-g002){#F2}
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###### Comparison of Heterotopic Ossification with Other Studies

![](cios-9-263-i001)

  Brooker grade   Edwards et al. (2015)[@B5]   Thilak et al. (2015)[@B2]   Downing et al. (2008)[@B6]   Higo et al. (2006)[@B7]   This study (2016)
  --------------- ---------------------------- --------------------------- ---------------------------- ------------------------- -------------------
  I               40 (8.1)                     2 (4.3)                     33 (29.7)                    34 (3.4)                  0
  II              5 (1.0)                      2 (4.3)                     4 (3.6)                      9 (0.9)                   1 (1.7)
  III             7 (1.4)                      2 (4.3)                     0                            9 (0.9)                   3 (5.0)
  IV              1 (0.2)                      1 (2.1)                     0                            0                         0
  Total           53 (10.7)                    7 (14.9)                    37 (33.3)                    52 (5.2)                  4 (6.7)

Values are presented as frequency (%).

###### Demographic Characteristics of the Patients

![](cios-9-263-i002)

                                  AS                  AVN                 p-value
  ------------------------------- ------------------- ------------------- ---------
  Hip (patient)                   30 (30)             30 (30)             \-
  Age (yr)                        39.6 (22--55)       42.6 (33--58)       0.334
  Sex (male/female)               26/4                26/4                \-
  BMI (kg/m^2^)                   25.7 (19.0--34.1)   24.9 (19.2--32.2)   0.485
  Follow-up (mo)                  69.0 (50--118)      71.5 (50--110)      0.334
  Acetabular cup                                                          \-
   Securefit (Stryker, USA)       13                  0                   
   Duraloc (Depuy, USA)           1                   0                   
   Pinacle (Depuy, USA)           0                   1                   
   Delta PF (Lima Corp., Italy)   16                  29                  
  Femoral stem                                                            \-
   Wagner cone (Zimmer, USA)      7                   2                   
   Accolade (Stryker, USA)        6                   0                   
   CLS (Zimmer, USA)              1                   0                   
   M/L taper (Zimmer, USA)        16                  28                  

Values are presented as mean (range).

AS: ankylosing spondylitis, AVN: avascular necrosis, BMI: body mass index.

###### Brooker\'s Classification of Heterotopic Ossification of the Hip Joint

![](cios-9-263-i003)

  Grade   Specification/region
  ------- --------------------------------------------------------------------------------
  0       No heterotopic ossification on the anteroposterior view of the hip
  I       Islands of bone within the soft tissues around the hip
  II      Bone spurs from the pelvis or femur with \> 1 cm gap between opposing surfaces
  III     Bone spurs with reduced space between the opposing bone surfaces (\< 1 cm)
  IV      Ankylosis of the hip joint

###### Comparison of Clinical and Radiological Outcomes between the Groups

![](cios-9-263-i004)

                                           AS                AVN             p-value
  ---------------------------------------- ----------------- --------------- ---------
  Clinical                                                                   
   HHS^\*^                                 55.6 ± 13.8       59.2 ± 2.8      0.001
   HHS^†^                                  92.8 ± 2.8        97.4 ± 2.6      0.012
   ROM (°)^\*^                             146.5 ± 13.2      182.6 ± 15.5    0.01
   ROM (°)^†^                              254.7 ± 17.2      260.4 ± 13.7    0.12
   Operation time (min)                    120.2 ± 26.2      79.5 ± 11.1     0.007
   Total drain output (mL)                 764.5 ± 355.4     510.5 ± 195.6   0.004
  Radiological                                                               
   Acetabular anteversion                  21.9 ± 6.8        18.9 ± 6.2      0.079
   Acetabular inclination                  36.6 ± 5.8        37.6 ± 4.3      0.476
   Femoral stem tilt                       1.1 ± 2.1         0.4 ± 1.2       0.012
   LLD (mm)^\*^                            3.1 ± 6.3         3.9 ± 5.7       0.357
   LLD (mm)^†^                             2.3 ± 5.7         3.4 ± 2.5       0.240
   Heterotopic ossification stage (case)   II (1), III (2)   III (1)         0.310
  Complication                                                               
   Deep infection                          1                 0               0.326
   Aseptic loosening                       1 (stem)          0               0.326

Values are presented as mean ± standard deviation.

AS: ankylosing spondylitis, AVN: avascular necrosis, HHS: Harris Hip Score, ROM: range of motion, LLD: leg length discrepancy.

^\*^Preoperative. ^†^Postoperative.
